Cerus Corp. (CERS) Announces Quarterly Earnings, Misses Expectations By $0.20 EPS
Cerus Corp. (NASDAQ:CERS) released its earnings data on Tuesday. The company reported ($0.29) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.09) by $0.20, Analyst Ratings Net reports. The company had revenue of $10.54 million for the quarter, compared to the consensus estimate of $10.34 million. Cerus Corp.’s revenue was up 27.8% compared to the same quarter last year.
A number of research firms have recently commented on CERS. Analysts at Cowen and Company raised their price target on shares of Cerus Corp. from $7.00 to $9.00 in a research note to investors on Monday, October 21st. On a related note, analysts at Wedbush raised their price target on shares of Cerus Corp. from $6.00 to $7.50 in a research note to investors on Monday, September 30th. They now have an “outperform” rating on the stock. Finally, analysts at Cantor Fitzgerald raised their price target on shares of Cerus Corp. from $6.00 to $7.00 in a research note to investors on Thursday, August 1st. They now have a “buy” rating on the stock.
Cerus Corp. (NASDAQ:CERS) traded up 3.27% during mid-day trading on Tuesday, hitting $6.94. 650,714 shares of the company’s stock traded hands. Cerus Corp. has a 1-year low of $2.68 and a 1-year high of $6.00. The stock has a 50-day moving average of $5. and a 200-day moving average of $4.90. The company’s market cap is $484.0 million.
Cerus Corporation is a biomedical products company focused on commercializing the INTERCEPT Blood System to enhance blood safety.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.